AUTL - BioNTech to invest $200M in Autolus as part of a CAR-T deal
2024-02-08 11:19:57 ET
More on Autolus Therapeutics
- Autolus Upgrades Leadership And Faces CAR-T Approval
- SA Analysts Comment On FDA Seeking Boxed Warning For CAR-T Cancer Therapies, Related Impact On AUTL
- Autolus Therapeutics: Pivotal Trial Using Familiar Approach, Possible Approval Coming Fast
- Autolus cell therapy accepted for FDA review in leukemia
- Autolus Therapeutics appoints Elisabeth Leiderman to board